RadNet, Inc.
RDNT Nasdaq· Services-Medical Laboratories
Last close · Oct 26, 2026
$70.05
KIRA · Stoqly’s AI analyst, in plain words
- RadNet, Inc. had $2.0B of revenue in fiscal 2025, up 11.5% on the year before. Over five years, revenue changed +13.7% a year on average.
- Its operating margin was 3.0%, down 2.7 pts: of every 100 in sales, about 3 is left after running the business.
- RadNet, Inc. lost $18.7M in fiscal 2025.
- RadNet, Inc. owes $323M more than it holds in cash, about 1.5 years of operating profit.
Market cap
$5.5B
P/E
—
Revenue
$2.0B
Net income
−$18.7M
Free cash flow
—
Operating margin
3.0%
RadNet, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+11.5%
Yes. Sales grew 11.5% last year.
Does it make a profit?
−0.9%
No. It lost money last year.
Is debt under control?
1.5x
Keep an eye on it. Repaying its debt would take 1.5 years of operating profit.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What RadNet, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Legal name
- RadNet, Inc.
- CIK
- 0000790526
RadNet, Inc. · RDNT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.3B | $1.4B | $1.6B | $1.8B | $2.0B |
| Revenue growth | 22.7% | 8.7% | 13.0% | 13.2% | 11.5% |
| Operating margin | 6.3% | 3.2% | 6.1% | 5.7% | 3.0% |
| Net income | $24.7M | $10.7M | $3.0M | $2.8M | −$18.7M |
| Net margin | 1.9% | 0.7% | 0.2% | 0.2% | −0.9% |
| Diluted EPS | $0.46 | $0.17 | $0.05 | $0.04 | −$0.25 |
| Cash | |||||
| Cash from operations | $149M | $146M | $221M | $233M | $299M |
| Share count change | 5.0% | 7.3% | 12.8% | 15.6% | 0.6% |
| Debt and strength | |||||
| Cash and short-term investments | $135M | $128M | $343M | $740M | $767M |
| Debt incl. finance leases | $755M | $852M | $830M | $1.0B | $1.1B |
| Shareholders' equity | $229M | $333M | $631M | $902M | $1.1B |
| Net debt / EBITDA | 3.5x | 4.5x | 2.1x | 1.1x | 1.5x |
| Current ratio | 0.9x | 0.8x | 1.3x | 2.1x | 1.8x |
| Interest coverage | 1.7x | 0.9x | 1.5x | 1.3x | 0.9x |
| Returns and quality | |||||
| Return on capital | 7.3% | 3.4% | 6.9% | 7.7% | 2.9% |
| Return on equity | 12.5% | 3.8% | 0.6% | 0.4% | −1.9% |
| Return on tangible equity | — | — | — | 2.5% | −55.3% |
| Piotroski F-score | 6 | 4 | 6 | 4 | 3 |
| Altman Z'' | 0.1 | −0.1 | 0.8 | 1.7 | 1.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$12.3M
5 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
RadNet, Inc. · RDNT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $70.05 a share, the company is worth $5.5B.
Source: SEC EDGAR XBRL filings (CIK 0000790526). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.